55 results match your criteria: "Royal Brompton National Heart and Lung Institute[Affiliation]"
Continuous veno-venous haemofiltration following cardio-pulmonary bypass. Indications and outcome in 35 patients.
Intensive Care Med
November 1993
Department of Anaesthesia and Intensive Care, Royal Brompton National Heart and Lung Institute, London, UK.
Objective: To study the impact of continuous veno-venous haemofiltration on survival in patients with acute renal failure (ARF) following cardio-pulmonary bypass (CPB) surgery.
Design: A retrospective study of all patients requiring haemofiltration after CPB over a 2 year period.
Setting: A 20 bedded, adult cardothoracic intensive care unit in a postgraduate teaching hospital.
Current concepts on mechanisms of force generation and maintenance in airways smooth muscle.
Pulm Pharmacol
December 1992
Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London, UK.
Effect of immunization with Freund's adjuvant and pneumolysin on histologic features of pneumococcal infection in the rat lung in vivo.
Infect Immun
November 1992
Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London, United Kingdom.
Immunization with Freund's adjuvant and pneumolysin and stimulation with Freund's adjuvant alone both reduced the severity of the pneumonia caused by injections of bacteria into the apical lobe bronchi of rats. Neither protocol influenced the incidence of pneumococcal bacteremia. Illness sufficiently severe to require sacrifice was delayed from 2.
View Article and Find Full Text PDFCould isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
Biochem Pharmacol
May 1992
Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London, U.K.
Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma.
Clin Exp Allergy
March 1992
Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London, U.K.